Avalon Pharma (Middle East Pharmaceutical)

Historical price data

Avalon Pharma, operating as Middle East Pharmaceutical, is a key contributor to Saudi Arabia's pharmaceutical sector, aiming to enhance healthcare accessibility through a diversified portfolio. The company leverages its public listing on Tadawul (4016.SR) to fund its growth and expansion strategies. Its focus spans multiple therapeutic areas, aligning with national health priorities and market demands in the Middle East and North Africa region.

Pharmaceutical manufacturing and development platform focused on formulation, analytical testing, and scale-up production for generic and innovative medicines, compliant with international and local regulatory standards.

Competes with multinational pharma companies (e.g., Pfizer, Novartis) and local Saudi manufacturers (e.g., SPIMACO, Jamjoom Pharma). Differentiation is achieved through local market expertise, established distribution, and cost-effective manufacturing aligned with national strategic goals.